Literature DB >> 33162101

NEAT1 Knockdown Inhibits Keloid Fibroblast Progression by miR-196b-5p/FGF2 Axis.

Jingzhe Yang1, Pingyang Deng2, Yonggang Qi2, Xinshu Feng3, Hailing Wen3, Fengping Chen3.   

Abstract

BACKGROUND: Keloid is a benign fibroproliferative tumor of the skin caused by abnormal wound healing process after skin injury. Long noncoding RNAs have been reported to be involved in the development of keloid. However, the role and mechanism of nuclear enriched abundant transcript 1 (NEAT1) in keloid are still unknown.
METHODS: Quantitative real-time polymerase chain reaction was performed to detect the expression of NEAT1, miR-196b-5p, and fibroblast growth factor 2 (FGF2). Western blot was conducted to measure the levels of collagen I, α-smooth muscle actin, fibronectin, and FGF2. Cell Counting Kit-8 assay and transwell assay were used to evaluate cell viability and migration, respectively. Dual-luciferase reporter assay was conducted to verify the targeting relationship between miR-196b-5p and NEAT1 or FGF2.
RESULTS: NEAT1 was increased and miR-196b-5p was decreased in keloid tissues and fibroblasts. NEAT1 knockdown or miR-196b-5p overexpression suppressed cell viability, migration, and extracellular matrix (ECM) component production in keloid fibroblasts. MiR-196 b-5p was a target of NEAT1, and NEAT1 overexpression reversed the effect of miR-196b-5p on keloid fibroblast progression. Moreover, we found that miR-196b-5p directly targeted FGF2. FGF2 knockdown suppressed keloid fibroblast viability, migration, and ECM protein production. FGF2 overexpression abolished the effect of miR-196b-5p overexpression on keloid fibroblast development.
CONCLUSIONS: NEAT1 silencing suppressed cell viability, migration, and ECM expression in keloid fibroblasts by regulating miR-196b-5p/FGF2 axis, indicating a promising strategy for keloid treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ECM; FGF2; Keloid; NEAT1; miR-196b-5p

Year:  2020        PMID: 33162101     DOI: 10.1016/j.jss.2020.09.038

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

2.  Vitamin D deficiency inhibits microRNA-196b-5p which regulates ovarian granulosa cell hormone synthesis, proliferation, and apoptosis by targeting RDX and LRRC17.

Authors:  Ting Wan; Huiting Sun; Zhilei Mao; Lina Zhang; Xia Chen; Yichao Shi; Yuwei Shang
Journal:  Ann Transl Med       Date:  2021-12

3.  Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) regulates fibroblast growth factor receptor substrate 2 (FRS2) by targeting microRNA (miR)-29-3p in hypertrophic scar fibroblasts.

Authors:  Qinghua Wu; Junjie Chen; Ziming Tan; Dehuai Wang; Jianwen Zhou; Dan Li; Ying Cen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Long non-coding RNA H19 aggravates keloid progression by upregulating SMAD family member 5 expression via miR-196b-5p.

Authors:  Zhichao Li; Cheng Gong; Huiming Wei
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

5.  Circular RNA hsa_circ_0043688 serves as a competing endogenous RNA for microRNA-145-5p to promote the progression of Keloids via Fibroblast growth factor-2.

Authors:  Ye Liu; Xin Wang; Ziqiao Ni; Yinqiu Li; Jiaqian Song; Fei Zhu; Xiaojing Li
Journal:  J Clin Lab Anal       Date:  2022-06-26       Impact factor: 3.124

6.  Silencing circular RNAPTPN12 promoted the growth of keloid fibroblasts by activating Wnt signaling pathway via targeting microRNA-21-5p.

Authors:  Fei Liu; Tao Li; Xiaoan Zhan
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.